Serum Monitoring and Phenotype Identification of Stage I Non-Small Cell Lung Cancer Patients

References

• Gould MK. Lung cancer screening with low-dose computed tomography. N Engl J Med 2014;371:1813–20.
   PubMed Web of Science ®Google Scholar
• Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD. Reduced lung-cancer mortality with low-dose computed tomographic screening. The national lung screening trial research team. N Engl J Med 2011;365:395–9.
   PubMed Web of Science ®Google Scholar
• Moyer VA. Screening for lung cancer: U.S. preventive services task force recommendation statement. Annals Intern Med 2014;160:330–8.
   PubMed Web of Science ®Google Scholar
• Pinsky PF, Berg CD Applying the national lung screening trial eligibility criteria to the US population: What percent of the population and of incident lung cancers would be covered? J Med Screen 2012;19:154–6.
   PubMed Web of Science ®Google Scholar
• Wood DE, Kazerooni E, Baum SL, Dransfield MT, Eapen GA, Ettinger DS, Hou L, Jackman DM, Klippenstein D, Kumar R, Lackner RP, Leard LE, Leung AN, Makani SS, Massion PP, Meyers BF, Otterson GA, Peairs K, Pipavath S, Pratt-Pozo C, Reddy C, Reid ME, Rotter AJ, Sachs PB, Schabath MB, Sequist LV, Tong BC, Travis WD, Yang SC, Gregory KM, Hughes M. National comprehension cancer network. Lung cancer screening, Version 1. 2015. J Nat Comprehen Cancer Net 2015;13:23–34.
   PubMed Web of Science ®Google Scholar
• Shen J, Liu Z, Todd NW, Zhang H, Liao J, Yu L, Guarnera MA, Li R, Cai L, Zhan M, Jiang F. Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers. BMC Cancer 2011;11:374–82.
   PubMed Web of Science ®Google Scholar
• Sozzi G, Boeri M, Rossi M, Verri C, Suatoni P, Bravi F, Roz L, Conte D, Grassi M, Sverzellati N, Marchiano A, Negri E, La Vecchia C, Pastorino U. Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: A correlative MILD trial study. J Clin Oncol 2014;32:768–73.
   PubMed Web of Science ®Google Scholar
• Luo XY, Chen HQ, Sun YH, Zhou JH, Wang WF, Liao P, Xiang CQ. Serum proteomic patterns may assist the diagnosis of solitary pulmonary nodules. Chinese J Oncol 2006;28:907–10.
   Google Scholar
• Pecot CV, Li M, Zhang XJ, Rajanbabu R, Calitri C, Bungum A, Jett JR, Putnam JB, Callaway-Lane C, Deppen S, Grogan EL, Carbone DP, Worrell JA, Moons KG, Shyr Y, Massion PP. Added value of a serum proteomic signature in the diagnostic evaluation of lung nodules. Cancer Epidemiol Biomarkers Prev 2012;21:786–92.
   PubMed Web of Science ®Google Scholar
• Vachani A, Pass HI, Rom WN, Midthun DE, Edell ES, Laviolette M, Li XJ, Fong PY, Hunsucker SW, Hayward C, Mazzone PJ, Madtes DK, Miller YE, Walker MG, Shi J, Kearney P, Fang KC, Massion PP. Validation of a multiprotein plasma classifier to identify benign lung nodules. J Thorac Oncol 2015;10:629–37.
   PubMed Web of Science ®Google Scholar
• Nolen BM, Langmead CJ, Choi S, Lomakin A, Marrangoni A, Bigbee WL, Weissfeld JL, Wilson DO, Dacic S, Siegfried JM, Lokshina AE. Serum biomarker profiles as diagnostic tools in lung cancer. Cancer Biomarkers 2011;10:3–12.
   PubMed Web of Science ®Google Scholar
• Hocker JR, Peyton MD, Lerner MR, Mitchell SL, Lightfoot SA, Lander TJ, Bates-Albers LM, Vu NT, Hanas RJ, Kupiec TC, Brackett DJ, Hanas JS. Serum discrimination of early-stage lung cancer patients using electrospray-ionization mass spectrometry. Lung Cancer 2011;74:206–11.
   PubMed Web of Science ®Google Scholar
• Jeter C, Hergenroeder GW, Hylin MJ, Redell JB, Moore AN, Dash P. Biomarkers for the diagnosis and prognosis of mild traumatic brain injury and concussion. J Neurotrauma 2013;30:657–70.
   PubMed Web of Science ®Google Scholar
• Hocker JR, Postier RG, Li M, Lerner MR, Lightfoot SA, Peyton MD, Deb SJ, Baker CM, Williams TL, Hanas RJ, Stowell DE, Lander TJ, Brackett DJ, Hanas JS. Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling. Cancer Lett 2015;359:314–24.
   PubMed Web of Science ®Google Scholar
• Hanas JS, Hocker JR, Cheung JY, Larabee JL, Lerner MR, Lightfoot SA; Morgan DL; Denson KD; Prejeant KC, Gusev Y, Smith BJ, Hanas RJ, Postier RG, Brackett DJ. Biomarker identification in human pancreatic cancer sera. Pancreas 2008;36:61–9.
   PubMed Web of Science ®Google Scholar
• Hocker JR, Mohammed A, Aston CE, Brewer M, Lightfoot SA; Rao CV; Hanas JS. Mass profiling of serum to distinguish mice with pancreatic cancer induced by a transgenic kras mutation. Int J Cancer 2013;133:2662–71.
   PubMed Web of Science ®Google Scholar
• Greene FL, Sobin LH. A worldwide approach to the TNM staging system: collaborative efforts of the AJCC and UICC. J Surg Oncol 2009;99:269–72.
   PubMed Web of Science ®Google Scholar
• Tuck MK, Chan DW, Chia D, Godwin AK, Grizzle WE, Krueger KE, Rom W, Sanda M, Sorbara L, Stass S, Wang W, Brenner DE. Standard operating procedures for serum and plasma collection: Early detection research network consensus statement standard operating procedure integration working group. J Proteome Res 2009;8:113–7.
   PubMed Web of Science ®Google Scholar
• Altman DG, Bland JM Statistics notes: diagnostic tests 2: predictive values. Brit Med J 1994;399:102.
   Web of Science ®Google Scholar
• Altman DG, Bland JM. Diagnostic tests. 1: Sensitivity and specificity. Brit Med J 1994;308:1552.
   PubMed Web of Science ®Google Scholar
• Postier RG, Lerner MR, Lightfoot SA, Vannarath R, Lane MM, Hanas JS, Brackett DJ. DNA ploidy and markovian analysis of neoplastic progression in experimental pancreatic cancer. J Histochem Cytochem 2003;51:303–9.
   PubMed Web of Science ®Google Scholar
• Ransohoff DR. Rules of evidence for cancer molecular-marker discovery and validation. Nat Rev Cancer 2004;4:309–14.
   PubMed Web of Science ®Google Scholar
• Guan W, Zhou M, Hampton CY, Benigno BB, Walker LD, Gray A, McDonald JF, Fernández FM. Ovarian cancer detection from metabolomic liquid chromatography/mass spectrometry data by support vector machines. BMC Bioinformat 2009;10:259–274.
   PubMed Web of Science ®Google Scholar
• Baker SG, Kramer BS, Srivastava S. Markers for early detection of cancer: Statistical guidelines for nested case-control studies. BMC Med Res Method 2002;2:4–12.
   PubMedGoogle Scholar
• Cooper WA, O'toole S, Boyer M, Horvath L, Mahar A What's new in non-small cell lung cancer for pathologists: the importance of accurate subtyping, EGFR mutations and ALK rearrangements. Pathology 2011;43:103–15.
   PubMed Web of Science ®Google Scholar
• Paech DC, Weston AR, Pavlakis N, Gill A, Rajan N, Barraclough H, Fitzgerald B, Van Kooten M. A systematic review of the interobserver variability for histology in the differentiation between squamous and nonsquamous non-small cell lung cancer. J Thorac Oncol 2011;6:55–63.
   PubMed Web of Science ®Google Scholar
• Hanas JS, Peyton MD, Lerner MR, Lightfoot SA, Deb SJ, Hanas RJ, Vu NT, Kupiec TC, Stowell DE, Brackett DJ, Dubinett SM, Hocker JR. Distinguishing patients with stage I lung cancer versus control individuals using serum mass profiling. Cancer Invest 2014;32:136–43.
   PubMed Web of Science ®Google Scholar
• Yu CJ, Yang PC, Shun CT, Lee YC, Kuo SH, Luh KT. Overexpression of MUC5 genes is associated with early post-operative metastasis in non-small-cell lung cancer. Intern J Cancer 1996;69:457–65.
   PubMed Web of Science ®Google Scholar
• Gan X, Wang J, Wang C, Sommer E, Kozasa T, Srinivasula S, Alessi D, Offermanns S, Simon MI, Wu D. PRR5L degradation promotes MTORC2-mediated PKCδ phosphorylation and cell migration downstream of Gα12. Nat Cell Biol 2001;14:686–96.
   Web of Science ®Google Scholar
• Saji H, Tsuboi M, Shimada Y, Kato Y, Hamanaka W, Kudo Y, Yoshida K, Matsubayashi J, Usuda J, Ohira T, Ikeda N. Gene expression profiling and molecular pathway analysis for the identification of early-stage lung adenocarcinoma patients at risk for early recurrence. Oncol Report 2013;29:1902–6.
   PubMed Web of Science ®Google Scholar
• de Chaisemartin L, Goc J, Damotte D, Validire P, Magdeleinat P, Alifano M, Cremer I, Fridman WH, Sautès-Fridman C, Dieu-Nosjean MC. Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer. Cancer Res 2011;71:6391–9.
   PubMed Web of Science ®Google Scholar
• McLerran D, Grizzle WE, Feng Z, Thompson IM, Bigbee WL, Cazares LH, Chan DW, Dahlgren J, Diaz J, Kagan J, Lin DW, Malik G, Oelschlager D, Partin A, Randolph TW, Sokoll L, Srivastava S, Srivastava S, Thornquist M, Troyer D, Wright GL, Zhang Z, Zhu L, Semmes OJ. SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer. Clinical Chem 2008;54:53–9.
   PubMed Web of Science ®Google Scholar
• Sekine Y, Katsura H, Koh E, Hiroshima K, Fujisawa T. Early detection of COPD is important for lung cancer surveillance. Eur Respir J 2012;39:1230–40.
   PubMed Web of Science ®Google Scholar
• Bigbee WL, Gopalakrishnan V, Weissfeld JL, Wilson DO, Dacic S, Lokshin AE, Siegfried JM. A multiplexed serum biomarker immunoassay panel discriminates clinical lung cancer patients from high-risk individuals found to be cancer-free by CT screening. J Thorac Oncol: Off Publ Int Assoc Study Lung Cancer 2012;7:698–708.
   Google Scholar
• Villanueva J, Shaffer DR, Philip J, Chaparro CA, Erdjument-Bromage H, Olshen AB, Fleisher M, Lilja H, Brogi E, Boyd J, Sanchez-Carbayo M, Holland EC, Cordon-Cardo C, Scher HI, Tempst P. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest 2006;116:271–84.
   PubMed Web of Science ®Google Scholar
• Bianchi ME. DAMPs, PAMPs, and alarmins: All we need to know about danger. J Leukocyte Biol 2007;81:1–5.
   PubMed Web of Science ®Google Scholar
• Kang JH, Lee EH, Park SW, Chung IY. MUC5AC expression through bidirectional communication of Notch and epidermal growth factor receptor pathways. J Immunol 2011;187:222–9.
   PubMed Web of Science ®Google Scholar
• Tyan YC, Wu HY, Su WC, Chen PW, Liao PC. Proteomic analysis of human pleural effusion. Proteomics 2005;5:1062–74.
   PubMed Web of Science ®Google Scholar
• Larabee JL, Hocker JR, Cheung JY, Gallucci RM, Hanas JS. Serum profiling of rat dermal exposure to JP-8 fuel reveals an acute-phase response. Toxicol Mech Meth 2008;18:41–51.
   PubMed Web of Science ®Google Scholar